Irritable bowel syndrome not linked to higher Parkinson’s risk, study finds

Il­lu­mi­na has re­ceived out­side in­ter­est in buy­ing or in­vest­ing in Grail, ac­cord­ing to com­ments that Il­lu­mi­na’s chief fi­nan­cial of­fi­cer made Tues­day at an in­vestor event,

Ar­bu­tus plans to lay off 40% of its staff af­ter end­ing one of three on­go­ing mid­stage he­pati­tis B tri­als. The de­ci­sion to cut the study